'Data Center GPUs' Prove Little Help for Intel Stock (NASDAQ:INTC)
Chip stock Intel (INTC) has been eagerly fighting to win back its presence in the data center. And as more data centers start taking on artificial intelligence (AI) operations, that has left Intel somewhat on the back foot. But Intel is working to make a comeback, and giving its Battlemage graphics processing unit (GPU) line some extra room to run. Sadly, this did little good for Intel stock, as shareholders rejected the notion and bolted for the exits, taking shares down nearly 4% in Friday afternoon's trading.
Confident Investing Starts Here:
Reports noted that Intel engineers are currently working on a Linux kernel to drive data center GPUs, which pretty much means Battlemage at this point. Intel already has a couple of entrants in the GPU field—the Arc B-Series and the Arc Pro B-Series—but with this new kernel being established, reports note, that will get Battlemage into the fray as well, doing more than just improving people's gaming experience.
The reports suggest that the new combination will come out under the Data Center GPU Flex Series, unless some fresh power is brought in that makes it more along the lines of the Data Center GPU Max Series. Word from the patch notes, meanwhile, notes that the new data center GPU line will have access to the Synopsis DesignWare I2C host adapter, which handles connection duties for a range of microcontrollers.
New Packaging, Too
Further, Intel is also working to bring out new word about its packaging, including one big breakthrough in the EMIB-T class. EMIB-T, noted a report from Tom's Hardware, will offer larger-size chip packages as well as greater options in power delivery, and even an improvement in heat spreader operations for a more reliable chip overall.
The EMIB-T design, meanwhile, is fairly similar to its EMIB lineup, but with the addition of 'through-silicon vias,' (TSVs) that lend access to better communications and power flow between dies and chiplets in the chip overall. That again should help improve efficiency and speeds, making chips made in this fashion more attractive overall.
Is Intel a Buy, Hold or Sell?
Turning to Wall Street, analysts have a Hold consensus rating on INTC stock based on one Buy, 26 Holds and four Sells assigned in the past three months, as indicated by the graphic below. After a 34.36% loss in its share price over the past year, the average INTC price target of $21.29 per share implies 8.76% upside potential.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Legendary Investor Bill Miller's Fund Is Loading Up on This 6.3%-Yielding Dividend Stock. Here's Why I Plan to Buy More of It, Too.
The hedge fund founded by investing legend Bill Miller and now run by his son initiated a new position in Verizon in Q1. Verizon's appeal includes a low valuation, growing free cash flow, and a juicy dividend. The main knock against this telecom stock is its high debt level. 10 stocks we like better than Verizon Communications › Many investment managers have a hard time beating the S&P 500. Not Bill Miller. When he ran Legg Mason Capital Management's Value Trust, Miller delivered higher returns than the S&P 500 for 15 consecutive years, from 1990 to 2005. Miller founded Miller Value Partners and served as its chairman and chief investment officer through May 2023. He passed the baton to his son, Bill Miller IV, who is carrying on the family legacy. Miller Value Partners' investment portfolio includes 34 stocks. The hedge fund added only three new positions in the first quarter of 2025. What was its biggest new holding? Verizon Communications (NYSE: VZ). Verizon isn't the only telecommunications giant in Miller Value Partners' portfolio. The fund also owns a position in AT&T. However, it reduced the stake in AT&T by roughly 78% in the first quarter. AT&T is now Miller Value Partners' seventh-smallest holding. The younger Miller seems to be trading telecom leaders, though. He initiated a new position in Verizon in the first quarter, buying 198,000 shares. This stake in Verizon was worth $8.98 million as of March 31, 2025. That might not seem like a huge amount, especially considering Verizon's market cap of nearly $183 billion. However, it's a big deal for Miller Value Partners. In one fell swoop, Verizon became the hedge fund's eighth-largest position, making up 4.09% of its total portfolio. Why did Miller Value Partners find Verizon so appealing? Just look at the hedge fund's middle name: value. Verizon's shares trade at a forward price-to-earnings ratio of only 9.2. By comparison, AT&T's forward earnings multiple is 13.4 -- nearly 46% higher. But Verizon isn't a value trap. The company's business is rocking along steadily. Verizon reported year-over-year growth on both the top and bottom lines in the first quarter. Its wireless service revenue of $20.8 billion led the industry. The company had its best wireless retail core prepaid net additions since it acquired TracFone in 2021. Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was the highest ever, with the strongest growth rate in nearly four years. Even better, Verizon's growth could accelerate in the not-too-distant future. The company expects to close its acquisition of Frontier Communications in early 2026. I suspect Bill Miller III and his team also liked Verizon's dividend. In addition to the juicy yield, Verizon has increased its dividend payout for 18 consecutive years. The company appears to be in a good position to keep that streak going, with its free cash flow soaring to $3.6 billion in the first quarter of 2025 from $2.7 billion in the prior-year period. While Miller Value Partners only recently initiated a position in Verizon, I've owned the telecom stock since last year. Why do I like Verizon? For the same reasons that Bill Miller III probably likes the stock. Its valuation is attractive. Its business is solid. Its free cash flow is growing. Its growth should accelerate. And its dividend is high. Is there anything not to like about Verizon? Sure. I'm not enthused about the company's debt load. Verizon had net unsecured debt of $115.1 billion at the end of the first quarter of 2025. On a positive note, this is $11 billion lower than the net unsecured debt in the first quarter of 2024. Verizon's net unsecured debt to consolidated adjusted EBITDA also improved year over year. Additionally, CFO Anthony Skiadis said in the Q1 earnings call that the company has "a clear pathway for meaningful debt reduction ahead of the closing of the Frontier transaction." Overall, I think the pluses for Verizon outweigh the minuses. I plan to buy even more shares of this telecom giant soon. Before you buy stock in Verizon Communications, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Verizon Communications wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Keith Speights has positions in Verizon Communications. The Motley Fool recommends Verizon Communications. The Motley Fool has a disclosure policy. Legendary Investor Bill Miller's Fund Is Loading Up on This 6.3%-Yielding Dividend Stock. Here's Why I Plan to Buy More of It, Too. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Cancer patients live 40pc longer after experimental treatment
Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major research shows. Chimeric antigen receptor (CAR) T-cell therapy is a form of immunotherapy where a patient's own T-cells – a type of white blood cell – are altered in a lab to target and kill cancer cells. The engineered cells are then reintroduced into the patient's bloodstream. CAR T-cell therapy works by genetically engineering a patient's T-cells to recognise and destroy cancer cells. T-cells are a type of white blood cell that can recognise and destroy foreign cells, including cancer cells, but because cancer is very good at evading immune detection, they often miss their mark. CAR T-cells are engineered to make them better at detecting cancer cells. The pioneering therapy had already been hailed by scientists as one of the most significant breakthroughs in treatment for its success in treating blood cancers. Now, new findings suggest it could also revolutionise treatment for solid tumours. Experts at the American Society of Clinical Oncology's (Asco) annual meeting in Chicago, the world's largest cancer conference, said the findings heralded 'a new generation of treatment'. Solid tumours represent roughly 90 per cent of all adult human cancers, including breast, lung and pancreatic cancer. Currently, over 650 CAR-Ts are in active development for a solid tumour indication. The new study – the first ever randomised controlled trial of CAR T-cell therapy in solid tumours – involved patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer. Those given the radical treatment lived on average approximately 40 per cent longer than patients who received standard care, a clinical trial found. The results have been simultaneously published in the medical journal The Lancet. Dr Carl June, a leading expert on CAR T-cell therapy at the University of Pennsylvania, who was not involved with the trial, said the findings were 'groundbreaking'. He said: 'This is an exciting study showing the first positive results from a randomised trial testing CAR T-cells for a solid cancer.' In the trial, over 100 patients in China with advanced gastric or GEJ cancer were randomised to receive either CAR T-cell therapy or one of the standard-of-care medications. Patients who received CAR T-cell therapy lived an average of 7.9 months after randomisation, compared to 5.5 months with standard care. Patients receiving the designer immunotherapy also experienced 3.3 months without the cancer advancing, versus 1.8 months in the standard care group. The researchers, from Peking University Cancer Hospital and Institute in Beijing, said CAR-T-cell therapy 'showed a statistically significant improvement in progression-free survival and clinically meaningful improvement in overall survival'. The results suggest CAR T-cell 'could represent a paradigm shift' in care, addressing a crucial unmet need for some patients, they added. A second study on CAR T-cell led by the University of Pennsylvania and due to be presented at Asco on Sunday, suggested the approach could also be used to treat brain tumours. Results from that trial are expected to show CAR T-cell can shrink tumours in glioblastoma, a notoriously aggressive and fast-growing brain cancer, and help patients live much longer. Oncologists in Chicago said they were increasingly optimistic about the potential of the therapy to revolutionise treatment of solid tumours, after dramatic success with blood cancers. Dr John Haanen, of the Netherlands Cancer Institute, who will deliver a presentation on CAR T-cell therapy at the Asco meeting, said the breakthroughs suggest 'a new generation of treatment that wasn't there for medical oncologists before'. Dr Catherine Elliott, director of research at Cancer Research UK, said: 'CAR T-cell therapy – a highly personalised treatment that modifies a patient's own immune cells to recognise and destroy their cancer – has already shown success in treating some blood cancers, but it hasn't yet worked well for solid tumours.' She said it was 'encouraging' to see early signs that it might help those with advanced stomach or gastroesophageal junction cancer, who lived an extra two and a half months longer than those given standard care. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Tom's Guide
5 hours ago
- Tom's Guide
9 gaming laptop deals I'd get right now — save on Acer, Dell and more
With their impressive GPUs, sleek design, and desktop class performance, it's no wonder that gaming laptops are so pricey. Fortunately, there are plenty of deals you can get right now on some of the best gaming laptops we've tested. One of the best deals right now comes from Best Buy. For a limited time, Best Buy is taking up to $500 off select gaming laptops from HP, MSI, Gigabyte and more. Below you'll find my picks for the best gaming laptop deals right now. For more savings, check out our RTX 40-series laptop deals and our back to school laptop sales roundup. This laptop from Gigabyte comes with some impressive specs and a solid price. It has 32GB RAM, an RTX 4060 GPU and an Intel i7-13620H processor. With the $200 discount, it's the only gaming laptop we've found that's worthwhile for under $1,000. If you're into indie games or older titles, there's no need to splurge on a high-end gaming laptop. This HP Victus 16 configuration is $300 off and it's equipped with a 16.1-inch 1080p display with 165Hz refresh, Core i7-14650HX CPU, 16GB of RAM, 1TB SSD, and RTX 4050 graphics. The RTX 4060 in this laptop should provide enough power for casual gaming. We also like the colored keyboard that's paired with the 17.3-inch 1080p display, Core i7-14650HX CPU, 16GB of RAM, and 1TB SSD. With these specs, it's ideal for play, work, or watching movies. One thing that makes the ASUS TUF Gaming F16 stand out from the crowd is the 16:10 aspect ratio display. Along with that, you'll get an Intel Core i7-13650HX, NVIDIA GeForce RTX 4060, 16GB DDR5 RAM and a 512GB SSD. For just over $1,000, those are some solid specs that gamers are sure to love. Save $450 on this RTX 4050-powered HP Omen 17 configuration, an ideal pick for relaxing, cozy games or graphically intensive games at lower settings. It's equipped with an Intel Core i7-i7-14700HX CPU, 16GB of RAM and a 512GB SSD. You also get a 16.1-inch 1080p 165Hz display. Boasting all the power a creative needs to create, edit, and store projects, this MSI Creator 16 AI Studio is worth checking out now that it's on sale. You get an Intel Core Ultra 9-185H CPU, 32GB of RAM, 1TB SSD, and an RTX 4070 GPU. We also like its 16-inch 1920 x 1200 (WUXGA) 165Hz display. This Lenovo Legion Pro 5i looks a tad dated by our reckoning, but don't disregard it. It's got a very capable RTX 4070 GPU, 16GB of RAM, and a QHD 165Hz display. The keyboard is nice and spacious, too. Alienware is Dell's gaming sub-brand, and this x16 R2 is a great example of how well they do things. There's an Intel Core Ultra 9, a very, very powerful GPU (an RTX 4090, no less), 32GB of RAM and a huge two terabyte SSD. It's reduced by $900, too! The only model on this list with the latest 50-series Nvidia GPU, the Alienware Area 51 is pricey, but it's packed to the gills with power. It has a massive 18-inch QHD+ screen with 300MHz refresh, Core Ultra 9-275HX CPU, 32GB of RAM, 2TB SSD, and a n RTX 5080 GPU.
